These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
892 related articles for article (PubMed ID: 24434637)
1. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637 [TBL] [Abstract][Full Text] [Related]
2. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy. Guo Y; Yu W; Sun D; Wang J; Li C; Zhang R; Babcock SA; Li Y; Liu M; Ma M; Shen M; Zeng C; Li N; He W; Zou Q; Zhang Y; Wang H Biochim Biophys Acta; 2015 Feb; 1852(2):319-31. PubMed ID: 24874076 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. Pang J; Peng H; Wang S; Xu X; Xu F; Wang Q; Chen Y; Barton LA; Chen Y; Zhang Y; Ren J Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1627-1641. PubMed ID: 30946956 [TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Ma H; Guo R; Yu L; Zhang Y; Ren J Eur Heart J; 2011 Apr; 32(8):1025-38. PubMed ID: 20705694 [TBL] [Abstract][Full Text] [Related]
5. mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism. Ge W; Ren J J Cell Mol Med; 2012 Mar; 16(3):616-26. PubMed ID: 21609394 [TBL] [Abstract][Full Text] [Related]
6. AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Ge W; Guo R; Ren J Free Radic Biol Med; 2011 Nov; 51(9):1736-48. PubMed ID: 21871561 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. Sun A; Zou Y; Wang P; Xu D; Gong H; Wang S; Qin Y; Zhang P; Chen Y; Harada M; Isse T; Kawamoto T; Fan H; Yang P; Akazawa H; Nagai T; Takano H; Ping P; Komuro I; Ge J J Am Heart Assoc; 2014 Sep; 3(5):e000779. PubMed ID: 25237043 [TBL] [Abstract][Full Text] [Related]
9. Acetaldehyde dehydrogenase 2 (ALDH2) deficiency exacerbates pressure overload-induced cardiac dysfunction by inhibiting Beclin-1 dependent autophagy pathway. Shen C; Wang C; Fan F; Yang Z; Cao Q; Liu X; Sun X; Zhao X; Wang P; Ma X; Zhu H; Dong Z; Zou Y; Hu K; Sun A; Ge J Biochim Biophys Acta; 2015 Feb; 1852(2):310-8. PubMed ID: 25086229 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function. Zhang Y; Babcock SA; Hu N; Maris JR; Wang H; Ren J BMC Med; 2012 Apr; 10():40. PubMed ID: 22524197 [TBL] [Abstract][Full Text] [Related]
11. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491 [TBL] [Abstract][Full Text] [Related]
12. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112 [TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases. Ma H; Yu L; Byra EA; Hu N; Kitagawa K; Nakayama KI; Kawamoto T; Ren J J Mol Cell Cardiol; 2010 Aug; 49(2):322-9. PubMed ID: 20362583 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α. Hu N; Ren J; Zhang Y Oncotarget; 2016 Nov; 7(47):76398-76414. PubMed ID: 27634872 [TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death. Liu W; Zhai X; Wang W; Zheng B; Zhang Z; Fan X; Chen Y; Wang J J Mol Cell Cardiol; 2018 Aug; 121():134-144. PubMed ID: 29981795 [TBL] [Abstract][Full Text] [Related]
16. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Gomes KM; Bechara LR; Lima VM; Ribeiro MA; Campos JC; Dourado PM; Kowaltowski AJ; Mochly-Rosen D; Ferreira JC Int J Cardiol; 2015 Jan; 179():129-38. PubMed ID: 25464432 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Ge W; Yuan M; Ceylan AF; Wang X; Ren J Biochim Biophys Acta; 2016 Apr; 1862(4):622-634. PubMed ID: 26692169 [TBL] [Abstract][Full Text] [Related]
18. ULK1-regulated autophagy: A mechanism in cellular protection for ALDH2 against hyperglycemia. Liu M; Lu S; He W; Zhang L; Ma Y; Lv P; Ma M; Yu W; Wang J; Zhang M; Zhang Y; Li Y Toxicol Lett; 2018 Feb; 283():106-115. PubMed ID: 29128638 [TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice. Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698 [TBL] [Abstract][Full Text] [Related]
20. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]